Financiers with a great deal of cash to invest have actually taken a bearish position on Novavax NVAX
And retail traders need to understand.
We discovered this today when the trade convention up on openly readily available alternatives history that we track here at Benzinga.
Whether these are organizations or simply rich people, we do not understand. However when something this huge occurs with NVAX, it frequently suggests someone understands something will take place.
So how do we understand what these financiers simply did?
Today, Benzinga’s alternatives scanner found 15 unusual alternatives trades for Novavax.
This isn’t typical.
The general belief of these big-money traders is divided in between 26% bullish and 66%, bearish.
Out of all of the unique alternatives we discovered, 12 are puts, for an overall quantity of $716,217, and 3 are calls, for an overall quantity of $183,569.
What’s The Cost Target?
Evaluating the Volume and Open Interest in these agreements, it appears that the huge gamers have actually been considering a rate window from $8.0 to $12.5 for Novavax throughout the previous quarter.
Volume & & Open Interest Advancement
In regards to liquidity and interest, the mean open interest for Novavax alternatives trades today is 6075.0 with an overall volume of 9,211.00.
In the following chart, we have the ability to follow the advancement of volume and open interest of call and put alternatives for Novavax’s huge cash trades within a strike cost series of $8.0 to $12.5 over the last one month.
Novavax Call and Put Volume: 30-Day Summary
Largest Options Trades Observed:
| Sign | PUT/CALL | Trade Type | Belief | Exp. Date | Ask | Quote | Cost | Strike Cost | Overall Trade Cost | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | PUT | TRADE | BEARISH | 01/16/26 | $ 4.95 | $ 4.85 | $ 4.95 | $ 12.50 | $ 179.1 K | 8.2 K | 613 |
| NVAX | PUT | SWEEP | BEARISH | 01/16/26 | $ 4.95 | $ 4.85 | $ 4.95 | $ 12.50 | $ 162.3 K | 8.2 K | 1.1 K |
| NVAX | CALL | SWEEP | BEARISH | 08/29/25 | $ 0.38 | $ 0.35 | $ 0.35 | $ 8.00 | $ 105.1 K | 12.1 K | 518 |
| NVAX | CALL | SWEEP | BULLISH | 01/16/26 | $ 1.17 | $ 1.12 | $ 1.17 | $ 9.00 | $ 52.9 K | 2.0 K | 526 |
| NVAX | PUT | TRADE | BEARISH | 10/17/25 | $ 2.4 | $ 2.24 | $ 2.4 | $ 10.00 | $ 48.0 K | 600 | 200 |
About Novavax
Novavax Inc is a biotechnology business that establishes vaccines. The business operates in the scientific phase of advancement with a concentrate on providing unique items that avoid a broad series of illness. It interacts with its entirely owned Swedish subsidiary to produce vaccine prospects to react to both recognized and emerging illness hazards. The business thinks its vaccine innovation has the possible to be used broadly to a wide range of human contagious illness. The business handles its company as one operating sector, the advancement and commercialization of vaccines. The business creates optimum income from the United States.
Because of the current alternatives history for Novavax, it’s now suitable to concentrate on the business itself. We intend to explore its existing efficiency.
Novavax’s Current Market Status
- With a trading volume of 11,850,475, the cost of NVAX is down by -7.21%, reaching $8.11.
- Existing RSI worths show that the stock is is presently neutral in between overbought and oversold.
- Next profits report is set up for 82 days from now.
Specialist Viewpoints on Novavax
In the last month, 1 professionals launched scores on this stock with a typical target cost of $7.0.
Unusual Options Activity Detected: Smart Cash on the Move
Benzinga Edge’s Unusual Options board areas possible market movers before they take place. See what positions huge cash is handling your preferred stocks. Click on this link for gain access to
* An expert from B of A Securities has actually modified its ranking downward to Underperform, changing the cost target to $7.
Trading alternatives includes higher threats however likewise uses the capacity for greater earnings. Smart traders alleviate these threats through continuous education, tactical trade modifications, making use of different signs, and remaining attuned to market characteristics. Stay up to date with the most recent alternatives trades for Novavax with Benzinga Pro for real-time informs.